S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
How major US stock indexes fared Friday, 12/1/2023
All the trading advice you’ve ever received boils down to this (Ad)
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
US joins in other nations in swearing off coal power to clean the climate
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
How major US stock indexes fared Friday, 12/1/2023
All the trading advice you’ve ever received boils down to this (Ad)
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
US joins in other nations in swearing off coal power to clean the climate
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
How major US stock indexes fared Friday, 12/1/2023
All the trading advice you’ve ever received boils down to this (Ad)
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
US joins in other nations in swearing off coal power to clean the climate
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
How major US stock indexes fared Friday, 12/1/2023
All the trading advice you’ve ever received boils down to this (Ad)
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
US joins in other nations in swearing off coal power to clean the climate

Repare Therapeutics (RPTX) Short Interest Ratio & Short Volume

$5.32
+0.17 (+3.30%)
(As of 12/1/2023 ET)
Compare
Today's Range
$4.92
$5.37
50-Day Range
$3.22
$12.70
52-Week Range
$3.08
$17.82
Volume
167,692 shs
Average Volume
483,847 shs
Market Capitalization
$224.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.80

Repare Therapeutics Short Interest Data

Current Short Volume
2,160,000 shares
Previous Short Volume
1,740,000 shares
Change Vs. Previous Month
+24.14%
Dollar Volume Sold Short
$11.43 million
Short Interest Ratio / Days to Cover
6.9
Last Record Date
November 15, 2023
Outstanding Shares
42,130,000 shares
Float Size
31,810,000 shares
Short Percent of Float
6.79%
Today's Trading Volume
167,692 shares
Average Trading Volume
483,847 shares
Today's Volume Vs. Average
35%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Repare Therapeutics ?

Sign up to receive the latest short interest report for Repare Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RPTX Short Interest Over Time

RPTX Days to Cover Over Time

RPTX Percentage of Float Shorted Over Time


Repare Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/20232,160,000 shares $11.43 million +24.1%6.8%6.9 $5.29
10/31/20231,740,000 shares $5.92 million +10.8%5.5%7.4 $3.40
10/15/20231,570,000 shares $8.29 million +23.6%4.9%9.9 $5.28
9/30/20231,270,000 shares $15.34 million +1.6%4.0%10.8 $12.08
9/15/20231,250,000 shares $12.90 million +4.2%3.9%12.3 $10.32
8/31/20231,200,000 shares $11.71 million -3.2%3.8%12.5 $9.76
8/15/20231,240,000 shares $12.05 million +0.8%3.9%12.1 $9.72
7/31/20231,230,000 shares $11.32 million -5.4%3.9%12.6 $9.20
7/15/20231,300,000 shares $14.14 million +2.4%4.1%13.7 $10.88
6/30/20231,270,000 shares $13.44 million -5.9%4.0%12.4 $10.58
6/15/20231,350,000 shares $16.67 million +7.1%4.3%13 $12.35
5/31/20231,260,000 shares $13.37 million -2.3%4.0%12.2 $10.61
5/15/20231,290,000 shares $13.08 million -4.4%4.1%12.8 $10.14
4/30/20231,350,000 shares $12.10 million -12.9%4.3%12 $8.96
4/15/20231,550,000 shares $14.06 million -8.3%5.0%12.6 $9.07
3/31/20231,690,000 shares $16.63 million +1.2%5.4%13.4 $9.84
3/15/20231,670,000 shares $16.60 million +6.4%5.4%11.6 $9.94
2/28/20231,570,000 shares $16.09 million +4.0%5.1%9.7 $10.25
2/15/20231,510,000 shares $17.41 million +4.9%4.9%9.2 $11.53
1/31/20231,440,000 shares $17.80 million -7.1%4.7%7.7 $12.36
1/15/20231,550,000 shares $19.92 million +22.1%5.0%8.8 $12.85
12/30/20221,270,000 shares $18.68 million +64.2%4.1%7.5 $14.71
12/15/2022773,300 shares $11.55 million -39.6%2.5%4.9 $14.93
11/30/20221,280,000 shares $20.52 million -18.0%4.2%8.9 $16.03
11/15/20221,560,000 shares $26.69 million +0.7%5.1%11.7 $17.11
10/31/20221,550,000 shares $23.34 million -1.9%5.1%12.6 $15.06
10/15/20221,580,000 shares $21.09 million -1.9%5.2%10.8 $13.35
9/30/20221,610,000 shares $19.53 million +4.6%5.3%10.5 $12.13
9/15/20221,540,000 shares $20.14 million -4.4%5.0%9.1 $13.08
8/31/20221,610,000 shares $19.19 million +5.2%5.3%7.9 $11.92
8/15/20221,530,000 shares $18.74 million -26.1%5.0%1.8 $12.25
7/31/20222,070,000 shares $26.16 million -1.0%6.8%2.5 $12.64
7/15/20222,090,000 shares $30.45 million +2.0%6.8%2.5 $14.57
6/30/20222,050,000 shares $28.68 million -15.6%6.7%2.4 $13.99
6/15/20222,430,000 shares $32.73 million +30.7%8.0%2.9 $13.47
5/31/20221,860,000 shares $17.07 million -4.6%6.4%2.3 $9.18
5/15/20221,950,000 shares $17.08 million -24.7%6.7%11.6 $8.76
4/30/20222,590,000 shares $28.49 million -12.8%8.9%15.8 $11.00
4/15/20222,970,000 shares $34.07 million +0.3%10.2%17.1 $11.47
3/31/20222,960,000 shares $42.15 million +6.1%10.2%17.2 $14.24













RPTX Short Interest - Frequently Asked Questions

What is Repare Therapeutics' current short interest?

Short interest is the volume of Repare Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 2,160,000 shares of RPTX short. 6.79% of Repare Therapeutics' shares are currently sold short. Learn More on Repare Therapeutics' current short interest.

What is a good short interest ratio for Repare Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPTX shares currently have a short interest ratio of 7.0. Learn More on Repare Therapeutics's short interest ratio.

Which institutional investors are shorting Repare Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Repare Therapeutics: Group One Trading L.P., Belvedere Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Repare Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.79% of Repare Therapeutics' floating shares are currently sold short.

Is Repare Therapeutics' short interest increasing or decreasing?

Repare Therapeutics saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 2,160,000 shares, an increase of 24.1% from the previous total of 1,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Repare Therapeutics' float size?

Repare Therapeutics currently has issued a total of 42,130,000 shares. Some of Repare Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Repare Therapeutics currently has a public float of 31,810,000 shares.

How does Repare Therapeutics' short interest compare to its competitors?

6.79% of Repare Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Repare Therapeutics: Immuneering Co. (13.03%), Inventiva S.A. (0.17%), Ovid Therapeutics Inc. (3.67%), Enanta Pharmaceuticals, Inc. (7.72%), Kamada Ltd. (0.05%), Vanda Pharmaceuticals Inc. (3.55%), Reneo Pharmaceuticals, Inc. (12.84%), Lifecore Biomedical, Inc. (6.23%), Puma Biotechnology, Inc. (5.07%), scPharmaceuticals Inc. (27.98%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Repare Therapeutics stock?

Short selling RPTX is an investing strategy that aims to generate trading profit from Repare Therapeutics as its price is falling. RPTX shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Repare Therapeutics?

A short squeeze for Repare Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RPTX, which in turn drives the price of the stock up even further.

How often is Repare Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPTX, twice per month. The most recent reporting period available is November, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:RPTX) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -